Interferon inhibits C-type virus at a posttranscriptional, prerelease step

Area of Science:

• Virology
• Immunology
• Cell Biology

Background:

• Chronic viral infections pose significant health challenges.
• Interferons are crucial cytokines in antiviral defense.
• Understanding interferon's mechanism against retroviruses like MLV is essential.

Purpose of the Study:

• To elucidate the mode of action of interferon in JLSV-5 cells chronically infected with Rauscher murine leukemia virus (MLV).
• To investigate the posttranscriptional effects of interferon on viral RNA and particle production.
• To determine the infectivity of virions produced by interferon-treated cells.

Main Methods:

• Studied the fate of pre-existing labeled viral RNA in interferon-treated cells.
• Assessed the infectivity/physical particle ratio of cell-associated and extracellular virus.
• Utilized actinomycin D to block RNA synthesis and cycloheximide to inhibit protein synthesis.

Main Results:

• Interferon inhibited labeled virus production at a posttranscriptional level, even after RNA synthesis arrest.
• Interferon prevented some pre-existing radioactive RNA from forming extracellular particles.
• Interferon-treated cells produced more cell-associated virus particles with reduced infectivity, indicating defective virions.

Conclusions:

• Interferon's antiviral state primarily functions at a posttranscriptional step against MLV.
• Interferon does not solely affect the release of fully assembled MLV particles.
• Virions produced by interferon-treated cells are defective, potentially lacking essential components.